GUFICBIO.NS WACC - Weighted Average Cost of Capital

The WACC of Gufic Biosciences Ltd (GUFICBIO.NS) is 13.5%.

The Cost of Equity of Gufic Biosciences Ltd (GUFICBIO.NS) is 13.60%.

The Cost of Debt of Gufic Biosciences Ltd (GUFICBIO.NS) is 10.40%.

	Range	Selected
Cost of equity	11.50% - 15.70%	13.60%
Tax rate	24.60% - 24.90%	24.75%
Cost of debt	7.80% - 13.00%	10.40%
WACC	11.4% - 15.6%	13.5%

WACC

GUFICBIO.NS WACC calculation

Category	Low	High

Long-term bond rate	6.9%	7.4%
Equity market risk premium	8.3%	9.3%
Adjusted beta	0.56	0.85

Additional risk adjustments	0.0%	0.5%
Cost of equity	11.50%	15.70%

Tax rate	24.60%	24.90%
Debt/Equity ratio	0.02	0.02
Cost of debt	7.80%	13.00%

After-tax WACC	11.4%	15.6%


Selected WACC	13.5%

GUFICBIO.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for GUFICBIO.NS:

cost_of_equity (13.60%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.56) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.